RVNC
Janus Henderson Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,107
| Closed | -$116K | – | 2576 |
|
|
2024
Q4 | $116K | Hold |
38,107
| – | – | ﹤0.01% | 2502 |
|
|
2024
Q3 | $198K | Hold |
38,107
| – | – | ﹤0.01% | 2433 |
|
|
2024
Q2 | $98.1K | Sell |
38,107
-435
| -1% | -$1.12K | ﹤0.01% | 2502 |
|
|
2024
Q1 | $189K | Buy |
38,542
+3
| +0% | +$15 | ﹤0.01% | 2436 |
|
|
2023
Q4 | $339K | Sell |
38,539
-60
| -0.2% | -$528 | ﹤0.01% | 2178 |
|
|
2023
Q3 | $443K | Buy |
38,599
+24
| +0.1% | +$275 | ﹤0.01% | 1986 |
|
|
2023
Q2 | $976K | Sell |
38,575
-51
| -0.1% | -$1.29K | ﹤0.01% | 1627 |
|
|
2023
Q1 | $1.24M | Buy |
38,626
+24,831
| +180% | +$799K | ﹤0.01% | 1509 |
|
|
2022
Q4 | $255K | Sell |
13,795
-33,795
| -71% | -$624K | ﹤0.01% | 2053 |
|
|
2022
Q3 | $1.28M | Buy |
47,590
+33,824
| +246% | +$913K | ﹤0.01% | 1519 |
|
|
2022
Q2 | $190K | Sell |
13,766
-19
| -0.1% | -$262 | ﹤0.01% | 2325 |
|
|
2022
Q1 | $269K | Buy |
13,785
+1
| +0% | +$20 | ﹤0.01% | 2287 |
|
|
2021
Q4 | $225K | Buy |
+13,784
| New | +$225K | ﹤0.01% | 2336 |
|